Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Bullboard Posts
Comment by Pra567on Oct 09, 2018 11:51am
277 Views
Post# 28766453

RE:RE:RE:RE:IPO'd with a 300 million dollar cap

RE:RE:RE:RE:IPO'd with a 300 million dollar cap
No emotions,  Go with the fact.  There is tough competition and they are late in the field. Stock will drop under $1 in a month.....rbm0524 wrote: Thanks for that useful comment, Pra567. Account created Aug 14, 2018 and already 50 ignores. Current market cap of $210 million is a 30%+/- discount to RTI, which is a relevant comparable. RTI's technology is supposedly far superior from a throughput perspective but they don't even have a production license. LABS is licensed for oil production, have already had their sales license inspection, have product in the vault ready for sale and have multiple supply agreements with LP's. I think LABS present market cap is quite reasonable compared to the rest of the market and entry at this point provides good value.


I agree, PRA567 is not up to speed on potential here.
Sales licence typically arrives within 15 days of inspection...so this will be news very soon and should pump the SP.
Lots of PR to come with other new deals etc...these guys are the real deal....sub 1.00 SP...dont think so
[/quote]

Bullboard Posts